Statistics for Stoke Therapeutics (id:8070 STOK)

Valuation metrics

Market cap

637.19M

Enterprise value

403.30M

Trailing P/E (ttm)

-4.80

Forward P/E

-4.85

PEG ratio

-4.85

Price/Sales (ttm)

38.06

Price/Book (mrq)

2.74

Enterprise Value/Revenue

24.09

Enterprise Value/EBITDA

-3.51

Overview

Shares outstanding

52.97M

Float

37.27M

Shares short

6.70M

% Held by insiders

0.04%

% Held by institutions

1.11%

Average volume (10 days)

491.84K

Average volume (90 days)

Price summary

52-Week low

3.77

52-Week high

17.58

52-Week change

64.65%

Beta

0.95

50-Day moving average

13.06

200-Day moving average

12.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-613.06%

Operational effectiveness

Return on assets

-27.50%

Return on equity

-52.06%

Income statement

Revenue (ttm)

0.33

Revenue per share (ttm)

0.33

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-115,030,000.00

Net income to common (ttm)

-105,457,000.00

Diluted EPS (ttm)

-2.08

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

239.20M

Total cash per share (mrq)

4.52

Total debt (mrq)

5.31M

Total Debt/Equity (mrq)

2.29

Current ratio (mrq)

508.60%

Book value per share (mrq)

4.38

Cash flow

Cash flow statement

-84,307,000.00

Levered free cash flow (LFCF)

-18,988,624.00